Rituximab for Prevention of Rejection After Renal Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Hoffmann-La Roche
Astellas Pharma GmbH
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT00565331
First received: November 28, 2007
Last updated: January 4, 2013
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)